AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Because individuals living with psoriasis are at a significantly increased risk for heart disease like stroke and heart attack, NPF spent the last half decade funding research exploring methods of prevention and risk reduction.
This transformational new gift directly supports the Psoriasis Prevention Initiative and a key study within the initiative, the “Prevention of cardiovascular disease and mortality in patients with psoriasis or psoriatic arthritis.” This is a multi-institutional effort led by Joel M. Gelfand, M.D. at the University of Pennsylvania and inclusive of a team of experts in the fields of dermatology, rheumatology, cardiology and implementation science. With this anonymous gift, NPF can accelerate and bolster the cardiovascular disease prevention efforts of these expert investigators to help people with psoriasis or psoriatic arthritis live full, healthy lives.
“In only a few years we’ve dramatically improved our understanding of the association between psoriasis and cardiovascular disease. It has already improved the lives of many individuals with psoriatic disease. This incredibly generous gift from a longtime NPF supporter allows us to expand our life saving efforts,” says Guy Eakin, Ph.D., NPF Chief Scientific and Medical Officer. “The better our researchers are able to understand the role of psoriatic disease and systemic inflammation in the development of cardiovascular disease, the more people we can help with new treatments and interventions.”
“This donor’s generosity is going to save lives. At NPF, we are working relentlessly to create a life free from the burdens of psoriatic disease, and there is no greater burden than a shortened lifespan. We have committed more than $5 million to address these issues, the single largest investment NPF has made to date. Now, this gift helps us enhance our impact,” says Leah M. Howard, J.D., President and CEO of NPF. “Cardiovascular disease is a terrifying prospect for anyone. It’s incredibly unfair that people with severe psoriasis are at such an elevated risk for these life altering or life-ending events. It’s our job to extinguish that fear.”
According to the NPF Psoriasis Health Indicator Report, compared to the general population, individuals with psoriasis experience a:
• 46% increased risk of cardiovascular disease mortality
• 17% increased risk of myocardial Infarction (heart attack)
• 19% increased risk of stroke
On behalf of the community of people impacted by psoriatic disease, NPF shares their sincerest appreciation for this generous gift and the impact it will have on the community.
About the National Psoriasis Foundation
Serving the community of people impacted by psoriatic disease for more than 55 years with support, advocacy, research, and education, the National Psoriasis Foundation is the leading nonprofit representing individuals with psoriasis and psoriatic arthritis. The mission of NPF is to drive efforts to cure psoriatic disease and improve the lives of more than 8 million individuals in the United States affected by this chronic immune-mediated disease. Learn more at psoriasis.org.
Matthew Werbach
National Psoriasis Foundation
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
